| Doping suspension |
07/29/2023 |
10/20/2027 |
Drostanolone metabolite (3?-hydroxy-2?-methyl-5?-androstan-17-one); Oxymetholone metabolite (17?-methyl-5?-androstane-3?,17?-diol); Mestanolone (17?-methyl-17?-hydroxy-5?-androstan-3-one), could be metabolized from Oxymetholone; Metandienone metabolites (6?-hydroxy-metandienone and 17?-methyl-17?- hydroxyandrost-1,4-dien-3-one); Oxymesterone (4,17?-dihydroxy-17?-methylandrost-4-en-3-one); Stanozolol metabolites (4?-hydroxy-stanozolol and 3'-hydroxy-stanozolol); Oxandrolone (17?-hydroxy-17?-methyl-2-oxa-5?-androstan-3-one); GW1516 (GW501516) metabolite (GW1516-sulfoxide); Ibutamoren |